Related references
Note: Only part of the references are listed.The endocannabinoid system and drug-associated contextual memories
Laila Asth et al.
BEHAVIOURAL PHARMACOLOGY (2022)
Beta-caryophyllene inhibits cocaine addiction-related behavior by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder
Ewa Galaj et al.
NEUROPSYCHOPHARMACOLOGY (2021)
Dissecting the role of CB1 and CB2 receptors in cannabinoid reward versus aversion using transgenic CB1- and CB2-knockout mice
Xia Li et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)
CB2 Receptor Involvement in the Treatment of Substance Use Disorders
Francisco Navarrete et al.
BIOMOLECULES (2021)
A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid
Hebaallah Mamdouh Hashiesh et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms
Xiang-Hu He et al.
FRONTIERS IN PHARMACOLOGY (2021)
The roles of cannabinoid CB1 and CB2 receptors in cocaine-induced behavioral sensitization and conditioned place preference in mice
Jadna B. Lopes et al.
PSYCHOPHARMACOLOGY (2020)
β-Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents
Yi He et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Opposing roles of CB1 and CB2 cannabinoid receptors in the stimulant and rewarding effects of cocaine
Pedro H. Gobira et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: The role of CB2 and PPAR-γ receptors
Dareen A. Youssef et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Alcohol-induced conditioned place preference is modulated by CB2 cannabinoid receptors and modifies levels of endocannabinoids in the mesocorticolimbic system
Ana Martin-Sanchez et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
Dopamine and addiction: what have we learned from 40 years of research
Marcello Solinas et al.
JOURNAL OF NEURAL TRANSMISSION (2019)
Progress in brain cannabinoid CB2 receptor research: From genes to behavior
Chloe J. Jordan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
The sesquiterpene beta-caryophyllene oxide attenuates ethanol drinking and place conditioning in mice
Aboagyewaah Oppong-Damoah et al.
HELIYON (2019)
Neuroscience of Addiction: Relevance to Prevention and Treatment
Nora D. Volkow et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Non-clinical toxicity of β-caryophyllene, a dietary cannabinoid: Absence of adverse effects in female Swiss mice
George Laylson da Silva Oliveira et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
Role of the endocannabinoid system in drug addiction
Jorge Manzanares et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Drug addiction: a curable mental disorder?
Jian-feng Liu et al.
ACTA PHARMACOLOGICA SINICA (2018)
Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats
Hai-Ying Zhang et al.
ADDICTION BIOLOGY (2017)
The peroxisome proliferator-activated receptor alpha agonist fenofibrate attenuates alcohol self-administration in rats
Colin N. Haile et al.
NEUROPHARMACOLOGY (2017)
Polypharmacological Properties and Therapeutic Potential of beta-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise
Charu Sharma et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Toxicological Evaluation of -Caryophyllene Oil: Subchronic Toxicity in Rats
D. Schmitt et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2016)
Endocannabinoids and striatal function: implications for addiction-related behaviours
Fabricio A. Moreira et al.
BEHAVIOURAL PHARMACOLOGY (2015)
The dopamine theory of addiction: 40 years of highs and lows
David J. Nutt et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Endocannabinoid signalling in reward and addiction
Loren H. Parsons et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol
Antonio Ortega-Alvaro et al.
ADDICTION BIOLOGY (2015)
PPARγ Activation Attenuates Opioid Consumption and Modulates Mesolimbic Dopamine Transmission
Giordano de Guglielmo et al.
NEUROPSYCHOPHARMACOLOGY (2015)
The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain
A. -L. Klauke et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Early phytocannabinoid chemistry to endocannabinoids and beyond
Raphael Mechoulam et al.
NATURE REVIEWS NEUROSCIENCE (2014)
The Development and Maintenance of Drug Addiction
Roy A. Wise et al.
NEUROPSYCHOPHARMACOLOGY (2014)
β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
Amine Bahi et al.
PHYSIOLOGY & BEHAVIOR (2014)
The cannabinoid receptor 2 agonist, β-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice
Shamma Al Mansouri et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
Hai-Ying Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Physiological Role of Peroxisome Proliferator-Activated Receptors Type Alpha on Dopamine Systems
Miriam Melis et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2013)
Cannabinoid CB2 receptor-mediated regulation of impulsive-like behaviour in DBA/2 mice
Francisco Navarrete et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABAA receptors
Maria S. Garcia-Gutierrez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Blockade of Nicotine Reward and Reinstatement by Activation of Alpha-Type Peroxisome Proliferator-Activated Receptors
Paola Mascia et al.
BIOLOGICAL PSYCHIATRY (2011)
Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
Zheng-Xiong Xi et al.
NATURE NEUROSCIENCE (2011)
The future of endocannabinoid-oriented clinical research after CB1 antagonists
Bernard Le Foll et al.
PSYCHOPHARMACOLOGY (2009)
Addiction and the brain antireward system
George F. Koob et al.
ANNUAL REVIEW OF PSYCHOLOGY (2008)
Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects
Emmanuel S. Onaivi et al.
PLOS ONE (2008)
Beta-caryophyllene is a dietary cannabinoid
Juerg Gertsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
JP Gong et al.
BRAIN RESEARCH (2006)
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
BJ Everitt et al.
NATURE NEUROSCIENCE (2005)
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence
B Le Foll et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Share Paper
